DK1309672T3 - Fremgangsmåde til fremstilling af infektiös reovirus - Google Patents
Fremgangsmåde til fremstilling af infektiös reovirusInfo
- Publication number
- DK1309672T3 DK1309672T3 DK01953084T DK01953084T DK1309672T3 DK 1309672 T3 DK1309672 T3 DK 1309672T3 DK 01953084 T DK01953084 T DK 01953084T DK 01953084 T DK01953084 T DK 01953084T DK 1309672 T3 DK1309672 T3 DK 1309672T3
- Authority
- DK
- Denmark
- Prior art keywords
- producing infectious
- infectious reovirus
- reovirus
- producing
- infectious
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
- A61K35/765—Reovirus; Rotavirus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
- C12N2510/02—Cells for production
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12032—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12051—Methods of production or purification of viral material
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US22402600P | 2000-08-10 | 2000-08-10 | |
PCT/CA2001/001054 WO2002012435A1 (en) | 2000-08-10 | 2001-07-20 | Method of producing infectious reovirus |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1309672T3 true DK1309672T3 (da) | 2005-10-10 |
Family
ID=22838987
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK05009952T DK1586634T3 (da) | 2000-08-10 | 2001-07-20 | Fremgangsmåde til fremstilling af infektiös reovirus |
DK01953084T DK1309672T3 (da) | 2000-08-10 | 2001-07-20 | Fremgangsmåde til fremstilling af infektiös reovirus |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK05009952T DK1586634T3 (da) | 2000-08-10 | 2001-07-20 | Fremgangsmåde til fremstilling af infektiös reovirus |
Country Status (19)
Country | Link |
---|---|
US (4) | US6528305B2 (pt) |
EP (2) | EP1586634B1 (pt) |
JP (2) | JP4009532B2 (pt) |
AR (1) | AR033993A1 (pt) |
AT (2) | ATE394475T1 (pt) |
AU (2) | AU7562801A (pt) |
BR (1) | BR0113122A (pt) |
CA (1) | CA2415749C (pt) |
DE (2) | DE60111747T2 (pt) |
DK (2) | DK1586634T3 (pt) |
ES (2) | ES2305940T3 (pt) |
HK (1) | HK1082765A1 (pt) |
IL (2) | IL153847A0 (pt) |
MX (1) | MXPA03000846A (pt) |
NZ (1) | NZ523510A (pt) |
PT (2) | PT1309672E (pt) |
TW (1) | TWI289158B (pt) |
WO (1) | WO2002012435A1 (pt) |
ZA (1) | ZA200300410B (pt) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6545492B1 (en) * | 1999-09-20 | 2003-04-08 | Europaisches Laboratorium Fur Molekularbiologie (Embl) | Multiple local probe measuring device and method |
TWI289158B (en) * | 2000-08-10 | 2007-11-01 | Oncolytics Biotech Inc | Method of producing infectious reovirus |
CA2437962C (en) * | 2001-03-16 | 2005-11-15 | Oncolytics Biotech Inc. | Method of extracting virus from cell culture |
US20040115170A1 (en) * | 2001-11-30 | 2004-06-17 | Brown Earl Garnet | Oncolytic virus |
CA2374388C (en) * | 2002-02-28 | 2005-07-12 | Matthew C. Coffey | The use of ribozymes in the detection of adventitious agents |
US20040005546A1 (en) | 2002-02-28 | 2004-01-08 | Oncolytics Biotech Inc. | Use of ribozymes in the detection of adventitious agents |
WO2003093460A1 (en) * | 2002-04-29 | 2003-11-13 | The Trustees Of The University Of Pennsylvania | Method for direct rescue and amplification of integrated viruses from cellular dna of tissues |
WO2003093463A1 (en) * | 2002-04-30 | 2003-11-13 | Oncolytics Biotech Inc. | Improved viral purification methods |
MXPA04011007A (es) * | 2002-05-09 | 2005-02-14 | Oncolytics Biotech Inc | Metodo para reducir el dolor usando virus oncoliticos. |
EP1944035A1 (en) | 2002-05-09 | 2008-07-16 | Oncolytics Biotech Inc. | Method for reducing pain using oncolytic viruses |
JP4546823B2 (ja) * | 2002-05-10 | 2010-09-22 | オンコリティクス バイオテク,インコーポレーテッド | 腫瘍崩壊性ウイルスによる放射線療法に対する新生物細胞の感作 |
US7901921B2 (en) | 2004-10-22 | 2011-03-08 | Oncolytics Biotech Inc. | Viral purification methods |
US7490608B2 (en) * | 2005-06-17 | 2009-02-17 | Nellcorr Puritan Bennett Llc | System and method for adjusting a gas delivery mask |
US10668119B2 (en) | 2005-08-01 | 2020-06-02 | Virocure, Inc. | Attenuated reovirus |
US10260049B2 (en) | 2005-08-01 | 2019-04-16 | Virocure, Inc. | Attenuated reovirus |
JP2009525989A (ja) * | 2006-02-13 | 2009-07-16 | オンコリティクス バイオテク,インコーポレーテッド | 腫瘍溶解性ウイルスの治療を増強させる局所的免疫抑制の使用 |
US8293498B2 (en) | 2006-12-20 | 2012-10-23 | Vanderbilt University | System for generation of viable reovirus from cloned cDNA |
WO2008127486A2 (en) * | 2006-12-29 | 2008-10-23 | Bacilligen, Inc. | Replication-proficient dsrna capsids and uses thereof |
EP2132315B1 (en) | 2007-03-12 | 2015-07-15 | Oncolytics Biotech Inc. | Reoviruses having modified sequences |
US10369171B2 (en) | 2007-03-13 | 2019-08-06 | Virocure, Inc. | Attenuated reoviruses for selection of cell populations |
TW200909581A (en) * | 2007-05-21 | 2009-03-01 | Oncolytics Biotech Inc | Mutant reoviruses and methods of making and using |
AU2008316276A1 (en) * | 2007-10-22 | 2009-04-30 | Oncolytics Biotech Inc. | Treatment regime for proliferative disorders |
US20110086005A1 (en) * | 2008-05-27 | 2011-04-14 | Oncolytics Biotech Inc. | Modulating interstitial pressure and oncolytic viral delivery and distribution |
EP2296679A4 (en) * | 2008-05-27 | 2012-03-21 | Oncolytics Biotech Inc | SUPPRESSION OF PRODUCTION OF PRO-INFLAMMATORY CYTOKINES DURING ONCOLYTIC REOVIRUS THERAPY |
WO2011126976A1 (en) | 2010-04-07 | 2011-10-13 | Vanderbilt University | Reovirus vaccines and methods of use therefor |
CN102985536B (zh) | 2010-04-14 | 2017-12-05 | Emd密理博公司 | 生产高效价、高纯度的病毒母液的方法及使用其的方法 |
TW201233803A (en) | 2010-12-02 | 2012-08-16 | Oncolytics Biotech Inc | Lyophilized viral formulations |
JP6034798B2 (ja) | 2010-12-02 | 2016-11-30 | オンコリティクス バイオテク,インコーポレーテッド | 液体ウイルス製剤 |
ES2796950T3 (es) | 2013-11-15 | 2020-11-30 | Oncolytics Biotech Inc | Virus oncolíticos y regímenes reforzados para tratamiento de cáncer |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4070453A (en) * | 1976-06-25 | 1978-01-24 | Syntex (U.S.A.) Inc. | Diploid porcine embryonic cell strains, cultures produced therefrom, and use of said cultures for production of vaccines |
US4559229A (en) * | 1982-07-20 | 1985-12-17 | Research Foundation | Avian proventriculitis vaccine |
US5023252A (en) | 1985-12-04 | 1991-06-11 | Conrex Pharmaceutical Corporation | Transdermal and trans-membrane delivery of drugs |
JPS6344532A (ja) | 1986-08-11 | 1988-02-25 | Biseibutsu Kagaku Kenkyusho:Kk | 豚のレオウイルス感染症ワクチン |
US5658779A (en) | 1992-03-20 | 1997-08-19 | Ligochem, Inc. | Method of adsorbing viruses from fluid compositions |
JPH08214876A (ja) | 1995-02-15 | 1996-08-27 | Chemo Sero Therapeut Res Inst | ウイルスの調製法 |
WO1998022588A2 (en) | 1996-11-20 | 1998-05-28 | Introgen Therapeutics, Inc. | An improved method for the production and purification of adenoviral vectors |
EP0993443A1 (de) | 1997-06-24 | 2000-04-19 | Basf Aktiengesellschaft | Verfahren zur herstellung von 4,4'-dihalogendiphenylsulfon |
US6136307A (en) * | 1997-08-13 | 2000-10-24 | Oncolytics Biotech Inc. | Reovirus for the treatment of cellular proliferative disorders |
US6110461A (en) * | 1997-08-13 | 2000-08-29 | Oncolytics Biotech Inc. | Reovirus for the treatment of neoplasia |
AR028039A1 (es) | 2000-05-03 | 2003-04-23 | Oncolytics Biotech Inc | Remocion de reovirus de celulas neoplasticas intermediadas por ras a partir de composiciones celulares mixtas |
TWI289158B (en) * | 2000-08-10 | 2007-11-01 | Oncolytics Biotech Inc | Method of producing infectious reovirus |
-
2001
- 2001-07-19 TW TW90117712A patent/TWI289158B/zh not_active IP Right Cessation
- 2001-07-20 PT PT01953084T patent/PT1309672E/pt unknown
- 2001-07-20 ES ES05009952T patent/ES2305940T3/es not_active Expired - Lifetime
- 2001-07-20 AU AU7562801A patent/AU7562801A/xx active Pending
- 2001-07-20 EP EP20050009952 patent/EP1586634B1/en not_active Expired - Lifetime
- 2001-07-20 CA CA 2415749 patent/CA2415749C/en not_active Expired - Lifetime
- 2001-07-20 MX MXPA03000846A patent/MXPA03000846A/es active IP Right Grant
- 2001-07-20 DK DK05009952T patent/DK1586634T3/da active
- 2001-07-20 WO PCT/CA2001/001054 patent/WO2002012435A1/en active IP Right Grant
- 2001-07-20 AT AT05009952T patent/ATE394475T1/de not_active IP Right Cessation
- 2001-07-20 NZ NZ523510A patent/NZ523510A/en unknown
- 2001-07-20 AT AT01953084T patent/ATE298788T1/de not_active IP Right Cessation
- 2001-07-20 BR BR0113122A patent/BR0113122A/pt not_active IP Right Cessation
- 2001-07-20 DK DK01953084T patent/DK1309672T3/da active
- 2001-07-20 DE DE2001611747 patent/DE60111747T2/de not_active Expired - Lifetime
- 2001-07-20 ZA ZA200300410A patent/ZA200300410B/xx unknown
- 2001-07-20 IL IL15384701A patent/IL153847A0/xx active IP Right Grant
- 2001-07-20 DE DE60133947T patent/DE60133947D1/de not_active Expired - Lifetime
- 2001-07-20 JP JP2002517726A patent/JP4009532B2/ja not_active Expired - Lifetime
- 2001-07-20 EP EP01953084A patent/EP1309672B1/en not_active Expired - Lifetime
- 2001-07-20 ES ES01953084T patent/ES2241844T3/es not_active Expired - Lifetime
- 2001-07-20 PT PT05009952T patent/PT1586634E/pt unknown
- 2001-07-20 AU AU2001275628A patent/AU2001275628B2/en not_active Expired
- 2001-08-02 US US09/920,012 patent/US6528305B2/en not_active Expired - Lifetime
- 2001-08-03 AR ARP010103738 patent/AR033993A1/es active IP Right Grant
-
2003
- 2003-01-08 US US10/337,911 patent/US6703232B2/en not_active Expired - Lifetime
- 2003-01-08 IL IL153847A patent/IL153847A/en unknown
- 2003-12-11 US US10/734,552 patent/US7049127B2/en not_active Expired - Lifetime
-
2006
- 2006-03-27 US US11/390,885 patent/US7429485B2/en not_active Expired - Lifetime
- 2006-04-03 HK HK06104055A patent/HK1082765A1/xx not_active IP Right Cessation
- 2006-08-30 JP JP2006234596A patent/JP2006314336A/ja not_active Withdrawn
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1309672T3 (da) | Fremgangsmåde til fremstilling af infektiös reovirus | |
DK1187231T3 (da) | Metode til fremstilling af oxid-superleder | |
DK1303478T3 (da) | Fremgangsmåde til fremstilling af substituerede octanoylamider | |
DK1978747T3 (da) | Fremgangsmåde til fjernelse af kodningsforvrængning | |
DK1296935T3 (da) | Fremgangsmåde til fremstilling af substituerede octanoylamider | |
DE60139615D1 (de) | Verbundmembran und herstellungsverfahren | |
DK1169314T3 (da) | Krystallinsk base af citalopram | |
DK1432319T3 (da) | Fremgangsmåde til fremstilling af hundefoder | |
DK1309582T3 (da) | Fremgangsmåde til fremstilling af citalopram | |
DK2135957T3 (da) | Fremgangsmåde til fremstilling af glucaner | |
DK1353923T3 (da) | Forbedret fremgangsmåde til syntese af carbapenem | |
DE60130046D1 (de) | Knotenauswahlverfahren | |
DK1326836T3 (da) | Fremgangsmåde til fremstilling af 3-amino-2-chlor-4-methylpyridin | |
DK1294659T3 (da) | Fremgangsmåde til isolering af katamin | |
DK1296970T3 (da) | Fremgangsmåde til fremstilling af citalopram | |
IS6716A (is) | Aðferðir við að framleiða sílostasól | |
DK1286940T3 (da) | Fremgangsmåde til fluormethylering af alkoholer | |
NO20032563D0 (no) | Filtreringsfremgangsmåte | |
DK1286941T3 (da) | Syntetisk fremgangsmåde til fluormethylering af halogenerede alkoholer | |
DE10294532D2 (de) | Künstlicher Lymphknoten | |
ES1048083Y (es) | Bielas avanzadas de empuje tangencial | |
DK1229109T3 (da) | Fremgangsmåde til fremstilling af glucose-1-phosphat | |
NO20023714L (no) | Ny koblingsprosess | |
DK1296983T3 (da) | Ny fremgangsmåde til fremstilling af pyrazolopyrimidinoner | |
SE0104471D0 (sv) | New method |